Overweight

Last Updated: October 12, 2022

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).

research-feedResearch feed
What is overweight?

Overweight refers to weighing more than what is considered normal or healthy for a given height. People with overweight are at a higher risk of negative health outcomes such as cardiovascular disease, diabetes, and mortality.[1][2][2] As of 2017–2018, approximately 31.1% of adults in the United States have overweight.[3] Worldwide, 39% of adults are estimated to have overweight as of 2016.[4]

How is overweight diagnosed?

Overweight is defined as having a body mass index (BMI) of 25 to 29.9 kilograms per meters squared (kg/m2); a person’s BMI is calculated by dividing their weight by the square of their height. More specifically, a person with:[5]

  • A BMI of <18.5 is “underweight”
  • A BMI of 18.5 to 24.9 is “normal weight”
  • A BMI of 25 to 29.9 has “overweight”
  • A BMI of 30 to 34.9 has “class I obesity”
  • A BMI of 35 to 39.9 has “class II obesity”
  • A BMI of >40 has “class III obesity”
What are some of the main medical treatments for overweight?

A person’s current health status and goals influence whether or not they should lose weight.

For people with overweight in addition to other cardiometabolic risk factors (high blood pressure, elevated blood sugar, dyslipidemia, etc.), weight loss is recommended. Typical treatment entails lifestyle changes, such as increasing physical activity and changing dietary patterns. Weight loss medications are sometimes used in people with overweight, but are more commonly used in people with obesity. Other weight-related comorbidities (e.g., diabetes, heart disease, and high blood pressure) may be managed with medications such as statins, antihypertensives, and diabetes medications.

On the other hand, if a person has overweight but does not have cardiometabolic risk factors, they are encouraged to maintain their weight rather than lose it.[6][5]

Have any supplements been studied for overweight?

Some supplements that have been studied for weight loss in people with overweight include but are not limited to conjugated linoleic acid, L-carnitine, and green tea extract. However, the evidence is insufficient to recommend them for weight loss.

How could diet affect overweight?

A general recommendation for weight loss is to be at a 500–750 kilocalorie deficit daily. Because many diets can be effective, the “right” diet will be different for everybody. In general, finding an easy-to-follow diet rich in fruits, vegetables, whole grains, and lean protein will allow for sustainable weight loss and health.[7] The most effective diet for weight loss is one that a person will adhere to.[8]

Are there any other treatments for overweight?

Although beneficial for weight loss, aerobic and resistance training can also help with issues that may come with overweight, such as lowering blood pressure, improving insulin sensitivity, decreasing appetite, and enhancing quality of life.[9] Time-restricted feeding may also be effective for weight loss and improving cardiometabolic risk factors in people with overweight.[10][11]

What causes overweight?

Simply put, overweight results from having a positive energy balance — consuming more energy from food than the body expends. However, many variables can impact calorie intake and energy expenditure, including genetics, socioeconomic status, physical activity, and the gut microbiome.[12]

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Don't miss out on the latest research

References
  1. ^Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DMAssociation of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.JAMA Cardiol.(2018-04-01)
  2. ^Global BMI Mortality Collaboration, Emanuele Di Angelantonio, Shilpa Bhupathiraju, David Wormser, Pei Gao, Stephen Kaptoge, Amy Berrington de Gonzalez, Benjamin Cairns, Rachel Huxley, Chandra Jackson, Grace Joshy, Sarah Lewington, JoAnn Manson, Neil Murphy, Alpa Patel, Jonathan Samet, Mark Woodward, Wei Zheng, Maigen Zhou, Narinder Bansal, Aurelio Barricarte, Brian Carter, James Cerhan, George Smith, Xianghua Fang, Oscar Franco, Jane Green, Jim Halsey, Janet Hildebrand, Keum Jung, Rosemary Korda, Dale McLerran, Steven Moore, Linda O'Keeffe, Ellie Paige, Anna Ramond, Gillian Reeves, Betsy Rolland, Carlotta Sacerdote, Naveed Sattar, Eleni Sofianopoulou, June Stevens, Michael Thun, Hirotsugu Ueshima, Ling Yang, Young Yun, Peter Willeit, Emily Banks, Valerie Beral, Zhengming Chen, Susan Gapstur, Marc Gunter, Patricia Hartge, Sun Jee, Tai-Hing Lam, Richard Peto, John Potter, Walter Willett, Simon Thompson, John Danesh, Frank HuBody-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continentsLancet.(2016 Aug 20)
  3. ^Fryar CD, Carroll MD, Afful JPrevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018(2021=01)
  4. ^Obesity and overweight
  5. ^Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R,AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.Endocr Pract.(2016-Jul)
  6. ^Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity SocietyCirculation.(2014 Jun 24)
  7. ^Koliaki C, Spinos T, Spinou Μ, Brinia ΜE, Mitsopoulou D, Katsilambros NDefining the Optimal Dietary Approach for Safe, Effective and Sustainable Weight Loss in Overweight and Obese Adults.Healthcare (Basel).(2018-Jun-28)
  8. ^Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, Ball GD, Busse JW, Thorlund K, Guyatt G, Jansen JP, Mills EJComparison of weight loss among named diet programs in overweight and obese adults: a meta-analysisJAMA.(2014 Sep 3)
  9. ^Oppert JM, Bellicha A, van Baak MA, Battista F, Beaulieu K, Blundell JE, Carraça EV, Encantado J, Ermolao A, Pramono A, Farpour-Lambert N, Woodward E, Dicker D, Busetto LExercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group.Obes Rev.(2021-07)
  10. ^Shinje Moon, Jiseung Kang, Sang Hyun Kim, Hye Soo Chung, Yoon Jung Kim, Jae Myung Yu, Sung Tae Cho, Chang-Myung Oh, Tae KimBeneficial Effects of Time-Restricted Eating on Metabolic Diseases: A Systemic Review and Meta-AnalysisNutrients.(2020 Apr 29)
  11. ^Marianna Pellegrini, Iolanda Cioffi, Andrea Evangelista, Valentina Ponzo, Ilaria Goitre, Giovannino Ciccone, Ezio Ghigo, Simona BoEffects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysisRev Endocr Metab Disord.(2020 Mar)
  12. ^Ellen P Williams, Marie Mesidor, Karen Winters, Patricia M Dubbert, Sharon B WyattOverweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health ProblemCurr Obes Rep.(2015 Sep)
  13. ^Ode JJ, Pivarnik JM, Reeves MJ, Knous JLBody mass index as a predictor of percent fat in college athletes and nonathletes.Med Sci Sports Exerc.(2007-Mar)
  14. ^André Tchernof, Jean-Pierre DesprésPathophysiology of human visceral obesity: an updatePhysiol Rev.(2013 Jan)
  15. ^Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A,Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.Diabetes Care.(2010-Apr)
  16. ^Bijari M, Jangjoo S, Emami N, Raji S, Mottaghi M, Moallem R, Jangjoo A, Saberi AThe Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis.Int J Endocrinol.(2021)